The EU's medicines regulator says there is no indication that the Oxford-AstraZeneca COVID-19 vaccine is linked to an increased risk of blood clots.
The BBC reports that the regulator said the number of cases in vaccinated people was no higher than in the general population.
The statement came after a number of countries, including Denmark and Norway, suspended the use of the jab.
The suspension followed reports that a small number of people had developed clots after receiving the vaccine.
There were also reports that a 50-year-old man had died in Italy after developing deep vein thrombosis following a dose of the jab.
However the European Medicines Agency said there is currently no indication that the vaccination has caused these conditions, which are not listed as side effects with this vaccine.
It says the vaccine's benefits continue to outweigh its risks and the vaccine can continue to be administered.
It said there had been 30 cases among the five million Europeans who have received the jab.
AstraZeneca said the drug's safety had been studied extensively in clinical trials.
In the UK, the Medicines and Healthcare products Regulatory Agency (MHRA) said there was no evidence the vaccine had caused problems, and people should still go and get vaccinated when asked to do so.
It says blood clots can occur naturally and are not uncommon.
More than 11 million doses of the COVID-19 AstraZeneca vaccine have now been administered across the UK.
[Source : BBC]
